Anastrozole 1 mg provides a cost-effective survival benefit, compared with megestrol acetate, for patients treated for advanced breast cancer

E Thompson; M Drummond; A Howell; W Jonat; J Brown

Anastrozole 1 mg provides a cost-effective survival benefit, compared with megestrol acetate, for patients treated for advanced breast cancer

E Thompson, M Drummond, A Howell, W Jonat, J Brown

Centre for Health Economics

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	OP27-OP27
Number of pages	1
Journal	European Journal of Cancer
Volume	33
Publication status	Published - Nov 1997

Cite this

@article{cadaa7c8244f405687b6281886250936,

title = "Anastrozole 1 mg provides a cost-effective survival benefit, compared with megestrol acetate, for patients treated for advanced breast cancer",

author = "E Thompson and M Drummond and A Howell and W Jonat and J Brown",

year = "1997",

month = nov,

language = "English",

volume = "33",

pages = "OP27--OP27",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier",

}

TY - JOUR

T1 - Anastrozole 1 mg provides a cost-effective survival benefit, compared with megestrol acetate, for patients treated for advanced breast cancer

AU - Thompson, E

AU - Drummond, M

AU - Howell, A

AU - Jonat, W

AU - Brown, J

PY - 1997/11

Y1 - 1997/11

M3 - Article

SN - 0959-8049

VL - 33

SP - OP27-OP27

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -